ProCE Banner Activity

Aiming High for Our Patients with Ulcerative Colitis: My Take on Treat-to-Target

Clinical Thought

Anita Afzali, MD describes her approach to goal setting when treating and monitoring patients with ulcerative colitis.

Released: July 26, 2022

Expiration: July 25, 2023

No longer available for credit.



Anita Afzali

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair
Department of Internal Medicine
Associate Chief Medical Officer
University of Cincinnati, UC Health System
The Scrubs & Heels Foundation
Cincinnati, Ohio


This activity is supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.

This activity is supported by educational grants from Amgen; and Ferring Pharmaceuticals, Inc.

Provided by

ProCE Banner



Ferring Pharmaceuticals, Inc.

Target Audience

NPs and PAs


Anita Afzali, MD, MPH, MHCM, FACG, AGAF: consultant/advisor/speaker: AbbVie, DiaSorin, Gilead Sciences, Janssen, Lilly, Pfizer, Takeda, TLL Pharmaceuticals.

None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose.



Additional Information

Program Medium

This program has been made available online.